To include your compound in the COVID-19 Resource Center, submit it here.

Enbrel sBLA briefing documents released

FDA released briefing documents for an sBLA from Amgen (AMGN) for Enbrel etanercept to treat ankylosing spondylitis.

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE